Metabolism of Retigabine (D-23129), a Novel Anticonvulsant
- 1 May 1999
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 27 (5) , 613-622
- https://doi.org/10.1016/s0090-9556(24)15258-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slicesXenobiotica, 1997
- D‐23129: A New Anticonvulsant CompoundCNS Drug Reviews, 1996
- D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizuresEuropean Journal of Pharmacology, 1996
- D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizuresEpilepsy Research, 1996
- Identification of Phenobarbital N-Glucosides as Urinary Metabolites of Phenobarbital in MiceJournal of Pharmaceutical Sciences, 1991
- New metabolites of the drug 5-aminosalicylic acid. I:N-β-D-glucopyranosyl-5-aminosalicylic acidXenobiotica, 1989
- High Performance Liquid Chromatography Coupled with Radioactivity Detection: A Powerful Tool for Determining Drug Metabolite Profiles in Biological FluidsZeitschrift für Naturforschung C, 1986
- Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidationGastroenterology, 1983
- The Carbon Monoxide-binding Pigment of Liver MicrosomesJournal of Biological Chemistry, 1964